The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
COLLECTIVE OBJECTIVE: To provide relevant information from official local regulatory agencies to the consumer in a format that facilitates informed, efficient, effective and economically sound therapeutic decisions.
MISSION: To support the transfer of knowledge about medicines throughout the care chain to increase the number of people who can live longer, healthier lives.
VIDAL GROUP is the first European CDS Pharmacological Knowledge provider to obtain CE marking class IIb MDR for its medical device for analysis of prescriptions, dispensations and administrations. The “VIDAL Sécurisation” technology is used to report the hazards and risks associated with a given patient’s medication prescriptions.
The company’s products are currently integrated into more than 400 medical software applications worldwide. Local operations in France, Germany, Portugal, Spain, Portugal, UK, Denmark, etc. And with presence in Latin America, Africa and the Middle East.
For more information, please visit: www.vidal-group.net/